ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EL01 | B | Ibrutinib - 420mg | 10597 | 180820/1 | IMBRUVICA | 420mg | 30 | Tablet, film coated | Oral | Mersaco | Cilag AG | Switzerland | 532,049,516 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EL01 | B | Ibrutinib - 420mg | 10597/388 | 180820/1 | IMBRUVICA | 420mg | 30 | Tablet, film coated | Oral | Mersaco | Cilag AG | Switzerland | L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 05/02/20 |